Delays in providing first medical contact to device time for STEMI can result in worse patient outcomes, highlighting the ...

Patients with AAV are associated with an increased risk for MI, particularly during the first 3 months after diagnosis.

Researchers from the Germans Trias i Pujol research institute (IGTP) have conducted a preclinical study on the effects of the ...

Acute myocardial infarction with or without ST-segment elevation (STEMI or non-STEMI) is a common cardiac emergency, with the potential for substantial morbidity and mortality. The management of ...

BACKGROUND: Previous research suggests that exposures to air pollution and nonoptimal temperatures are associated with a ...

A study has shown that patients who have experienced acute myocardial infarction have a higher risk of developing blood ...

The following is a summary of “Endocrine response in cardiogenic shock complicating myocardial infarction: the prognostic value of growth hormone and IGF-1,” published in the May 2025 issue of Journal ...

Myocardial ischemia is a drop in blood flow to the heart. Myocardial infarction, or heart attack, occurs when death or damage occurs in the muscle tissue of the heart due to low blood supply.

Background: Major noncardiac surgery carries high rates of postoperative myocardial injury and other complications. Remote ischemic preconditioning (RIPC) was reported to decrease these complications.

This page lists all known medications that could potentially lead to 'Myocardial infarction' as a side effect. It's important to note that mild side effects are quite common with medications.

The symptoms of myocardial infarction include: 1. Chest pain also known as angina or discomfort occurring right in the centre of the chest. It also feels like a heavy, tight pressure ...